Drugs / UCB4019
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02873767 | Aug 2016 → Feb 2017 | — | UCB Biopharma S.P.R.L. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCB4019 | “Active substance: UCB4019” NCT02873767 ↗ |
| Route | Subcutaneous | “Route of Administration: subcutaneously” NCT02873767 ↗ |